LCN2 and Nephropathy: This study revealed that, concerning urea, creatinine, and NGAL, infliximab declined their serum levels given in a dose of (5 mg/kg, i.p.), and in this context, Saritemur et al. (2015) verified that infliximab decreased the blood level of creatinine and blood urea nitrogen in a rat model of glycerol contrast-stimulated nephropathy (Saritemur et al. 2015).